Amphibole compositional trends in oversaturated and undersaturated alkaline plutonic ring-complexes

ABsrRAcr Amphiboles from different alkaline ring-complexes, representing both silica-oversaturated and silica-undersaturated petrographic associations, have been studied in relation to their host rocks. Textural, optical and chemical evidence emphasizes major amphibole compositional trends related to host-rock chemistry. In rocks whose agpaitic coefficient is less than 0.9, the Ca + Alt" content of amphiboles is more than 2.5, whereas it is less than 2.5 in agpaitic rocks (NazO*K2O,/ALO" > 0.9). This feature is shown firstly by the presence of solid-solution series from kaersutite to hornblende or hastingsite with substitutions I Ti € NaAAl. Ti + O <+ Fe3* + OH-and CaAl <= NaSi predominating in silica-undersaturated rock series and NaAl = n Si in basic and intermediate rocks from silica-oversaturated series. Secondly, this feature is shown by tbe presence of solid-solution series from actinolite or barroisite to winchite. with CaA|" P Na Si substitution or to katophorite, richterite and then arfvedsonite with balanced substitutions as n Fes" c> NaFe2+ and CaAlt" <2 Na Si. The first trends are related to early magmatic stages, and the second to late magmatic stages. The absence of (Ca + Alb)-rich amphiboles in agpaitic rocks and an observed break between (Ca + Alr")-rich amphiboles and (Ca .-1-Ali")-poor amphiboles suggest that (Ca + Alt')-rich amphibole stability is controlled by magma alkalinity. One argument is based on the description of a reaction, involving hastingsite and a residual liquid, which results in the crystallization of clinopyroxene and Ti-magnetite, and in the addition of potential analcime to the residual liquid. This alkalinization of the liquid ultimately produces a peralkaline concentrate

The statistical nature of leakage in SSE schemes and its role in passive attacks

Encrypted search schemes have been proposed to address growing privacy concerns. However, several leakage-abuse attacks have highlighted the shortcomings of these schemes. The literature remains vague about the consequences of these attacks for real-world applications: are these attacks dangerous in practice? Is it safe to use these schemes? Do we even need countermeasures? This paper introduces a novel mathematical model for attackers\u27 knowledge using statistical estimators. Our model reveals that any attacker\u27s knowledge is inherently noisy, which limits attack effectiveness. This inherent noise can be considered a security guarantee, a natural attack mitigation. Capitalizing on this insight, we develop a risk assessment protocol to guide real-world deployments. Our findings demonstrate that limiting the index size is an efficient leverage to bound attack accuracy. Finally, we employ similar statistical methods to enhance attack analysis methodology. Hence, our work offers a fresh perspective on SSE attacks and provides practitioners and researchers with novel methodological tools

Efficacy and safety of IVIG in CIDP : Combined data of the PRIMA and PATH studies

Intravenous immunoglobulin (IVIG) is a potential therapy for chronic inflammatory demyelinating polyneuropathy (CIDP). To investigate the efficacy and safety of the IVIG IgPro10 (Privigen) for treatment of CIDP, results from Privigen Impact on Mobility and Autonomy (PRIMA), a prospective, open-label, single-arm study of IVIG in immunoglobulin (Ig)-naive or IVIG pre-treated subjects (NCT01184846, n = 28) and Polyneuropathy And Treatment with Hizentra (PATH), a double-blind, randomized study including an open-label, single-arm IVIG phase in IVIG pre-treated subjects (NCT01545076, IVIG restabilization phase n = 207) were analyzed separately and together (n = 235). Efficacy assessments included change in adjusted inflammatory neuropathy cause and treatment (INCAT) score, grip strength and Medical Research Council (MRC) sum score. Adverse drug reactions (ADRs) and ADRs/infusion were recorded. Adjusted INCAT response rate was 60.7% in all PRIMA subjects at Week 25 (76.9% in IVIG pre-treated subjects) and 72.9% in PATH. In the pooled cohort (n = 235), INCAT response rate was 71.5%; median time to INCAT improvement was 4.3 weeks. No clear demographic differences were noticed between early (responding before Week 7, n = 148) and late responders (n = 21). In the pooled cohort, median change from baseline to last observation was -1.0 (interquartile range -2.0; 0.0) point for INCAT score; +8.0 (0.0; 20.0) kPa for maximum grip strength; +3.0 (1.0; 7.0) points for MRC sum score. In the pooled cohort, 271 ADRs were reported in 105 subjects (44.7%), a rate of 0.144 ADRs per infusion. This analysis confirms the efficacy and safety of IgPro10, a recently FDA-approved IVIG for CIDP, in a population of mainly pre-treated subjects with CIDP [Correction added on 14 March 2019 after first online publication: the INCAT response rate has been corrected.].Peer reviewe

Herpes simplex virus and varicella zoster virus, the house guests who never leave.

Human alphaherpesviruses including herpes simplex viruses (HSV-1, HSV-2) and varicella zoster virus (VZV) establish persistent latent infection in sensory neurons for the life of the host. All three viruses have the potential to reactivate causing recurrent disease. Regardless of the homology between the different virus strains, the three viruses are characterized by varying pathologies. This review will highlight the differences in infection pattern, immune response, and pathogenesis associated with HSV-1 and VZV

The SARS algorithm: detrending CoRoT light curves with Sysrem using simultaneous external parameters

Surveys for exoplanetary transits are usually limited not by photon noise but rather by the amount of red noise in their data. In particular, although the CoRoT spacebased survey data are being carefully scrutinized, significant new sources of systematic noises are still being discovered. Recently, a magnitude-dependant systematic effect was discovered in the CoRoT data by Mazeh & Guterman et al. and a phenomenological correction was proposed. Here we tie the observed effect a particular type of effect, and in the process generalize the popular Sysrem algorithm to include external parameters in a simultaneous solution with the unknown effects. We show that a post-processing scheme based on this algorithm performs well and indeed allows for the detection of new transit-like signals that were not previously detected.Comment: MNRAS accepted. 5 pages, 3 figure

a planned ancillary analysis of the coVAPid cohort

Funding: This study was supported in part by a grant from the French government through the «Programme Investissement d’Avenir» (I-SITE ULNE) managed by the Agence Nationale de la Recherche (coVAPid project). The funders of the study had no role in the study design, data collection, analysis, or interpreta tion, writing of the report, or decision to submit for publication.BACKGROUND: Patients with SARS-CoV-2 infection are at higher risk for ventilator-associated pneumonia (VAP). No study has evaluated the relationship between VAP and mortality in this population, or compared this relationship between SARS-CoV-2 patients and other populations. The main objective of our study was to determine the relationship between VAP and mortality in SARS-CoV-2 patients. METHODS: Planned ancillary analysis of a multicenter retrospective European cohort. VAP was diagnosed using clinical, radiological and quantitative microbiological criteria. Univariable and multivariable marginal Cox's regression models, with cause-specific hazard for duration of mechanical ventilation and ICU stay, were used to compare outcomes between study groups. Extubation, and ICU discharge alive were considered as events of interest, and mortality as competing event. FINDINGS: Of 1576 included patients, 568 were SARS-CoV-2 pneumonia, 482 influenza pneumonia, and 526 no evidence of viral infection at ICU admission. VAP was associated with significantly higher risk for 28-day mortality in SARS-CoV-2 (adjusted HR 1.70 (95% CI 1.16-2.47), p = 0.006), and influenza groups (1.75 (1.03-3.02), p = 0.045), but not in the no viral infection group (1.07 (0.64-1.78), p = 0.79). VAP was associated with significantly longer duration of mechanical ventilation in the SARS-CoV-2 group, but not in the influenza or no viral infection groups. VAP was associated with significantly longer duration of ICU stay in the 3 study groups. No significant difference was found in heterogeneity of outcomes related to VAP between the 3 groups, suggesting that the impact of VAP on mortality was not different between study groups. INTERPRETATION: VAP was associated with significantly increased 28-day mortality rate in SARS-CoV-2 patients. However, SARS-CoV-2 pneumonia, as compared to influenza pneumonia or no viral infection, did not significantly modify the relationship between VAP and 28-day mortality. CLINICAL TRIAL REGISTRATION: The study was registered at ClinicalTrials.gov, number NCT04359693.publishersversionpublishe

Finishing the euchromatic sequence of the human genome

The sequence of the human genome encodes the genetic instructions for human physiology, as well as rich information about human evolution. In 2001, the International Human Genome Sequencing Consortium reported a draft sequence of the euchromatic portion of the human genome. Since then, the international collaboration has worked to convert this draft into a genome sequence with high accuracy and nearly complete coverage. Here, we report the result of this finishing process. The current genome sequence (Build 35) contains 2.85 billion nucleotides interrupted by only 341 gaps. It covers ∼99% of the euchromatic genome and is accurate to an error rate of ∼1 event per 100,000 bases. Many of the remaining euchromatic gaps are associated with segmental duplications and will require focused work with new methods. The near-complete sequence, the first for a vertebrate, greatly improves the precision of biological analyses of the human genome including studies of gene number, birth and death. Notably, the human enome seems to encode only 20,000-25,000 protein-coding genes. The genome sequence reported here should serve as a firm foundation for biomedical research in the decades ahead

Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome associated with COVID-19: An Emulated Target Trial Analysis.

RATIONALE: Whether COVID patients may benefit from extracorporeal membrane oxygenation (ECMO) compared with conventional invasive mechanical ventilation (IMV) remains unknown. OBJECTIVES: To estimate the effect of ECMO on 90-Day mortality vs IMV only Methods: Among 4,244 critically ill adult patients with COVID-19 included in a multicenter cohort study, we emulated a target trial comparing the treatment strategies of initiating ECMO vs. no ECMO within 7 days of IMV in patients with severe acute respiratory distress syndrome (PaO2/FiO2 <80 or PaCO2 ≥60 mmHg). We controlled for confounding using a multivariable Cox model based on predefined variables. MAIN RESULTS: 1,235 patients met the full eligibility criteria for the emulated trial, among whom 164 patients initiated ECMO. The ECMO strategy had a higher survival probability at Day-7 from the onset of eligibility criteria (87% vs 83%, risk difference: 4%, 95% CI 0;9%) which decreased during follow-up (survival at Day-90: 63% vs 65%, risk difference: -2%, 95% CI -10;5%). However, ECMO was associated with higher survival when performed in high-volume ECMO centers or in regions where a specific ECMO network organization was set up to handle high demand, and when initiated within the first 4 days of MV and in profoundly hypoxemic patients. CONCLUSIONS: In an emulated trial based on a nationwide COVID-19 cohort, we found differential survival over time of an ECMO compared with a no-ECMO strategy. However, ECMO was consistently associated with better outcomes when performed in high-volume centers and in regions with ECMO capacities specifically organized to handle high demand. This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives License 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/)

Jean-Marc LEGER – Commissaire Général à la francophonie

Je suis d’autant plus sensible à l’invitation qui m’est faite de vous adresser la parole au terme de ce colloque que je n’ai plus de titre particulier à parler de coopération inter-universitaire, en raison de mes nouvelles fonctions au sein de l’appareil gouvernemental. Mais il va de soi que j’y reste profondément attaché. J’ai assisté avec beaucoup d’intérêt à vos travaux de cet après-midi : j’ai été frappé à la fois par la ferveur que suscite visiblement chez vous la coopération inter-unive..